1. Introduction {#sec1-molecules-24-00033}
===============

Ginseng, the king of herbs in the Orient, has always received a lot of attention, not only as a therapeutic medicinal herb, but also as a health supplement. According to the different growing environments and diverse cultivation methods, there two kinds of ginseng are distinguished in the Chinese Pharmacopoeia: cultivated ginseng (CG) and mountain-cultivated ginseng (MCG). CG is cultivated artificially in gardens, while MCG is grown for at least 10 years \[[@B1-molecules-24-00033],[@B2-molecules-24-00033]\]. MCG, also called "Lin-Xia-Shan-Shen", can be regarded as a replacement of wild ginseng. MCG is of better quality than CG and offers more production than wild ginseng \[[@B3-molecules-24-00033]\]. Actually, the adulteration or falsification of the cultivation age of MCG has always been a serious problem in the MCG commercial market. As we all know, the chemical components and biological activities of ginseng with different cultivation ages are distinct \[[@B4-molecules-24-00033],[@B5-molecules-24-00033]\], and more aged ginseng is usually of higher economic value. In an investigation of the characteristic components for distinguishing CG (4--7-year of age) and MCG (with 15-years of growth), 12 compounds, including ginsenoside Ra~3~/isomer, gypenoside XVII, quinquenoside R~1~, ginsenoside Ra~7~, notoginsenoside Fe, ginsenoside Ra~2~, ginsenoside Rs~6~/Rs~7~, malonyl ginsenoside Rc, malonyl ginsenoside Rb~1~, malonyl ginsenoside Rb~2~, palmitoleic acid, and ethyl linoleate were regarded as the characteristic chemical markers for the discrimination \[[@B6-molecules-24-00033]\]. Recently, a UPLC/QTOF- MS-based metabolomics approach was applied to the global metabolite profiling of MCG leaf samples aged from 6 to 18 years, and the authors claimed that the approach could also be applied to discriminate MCG root ages indirectly \[[@B7-molecules-24-00033]\]. It is undoubted that the developed method can be used as a standard protocol for discriminating and predicting MCG leaf ages directly, but there might be some inaccuracy and uncertainty when discriminating MCG root ages indirectly.

In the past decades, some analytical methods focusing on ginsenosides had been used to distinguish MCG from CG, such as thin layer chromatography (TLC), or high performance liquid chromatography (HPLC) \[[@B8-molecules-24-00033],[@B9-molecules-24-00033]\]. However, these technologies require lots of time and energy, and the results cannot provide a comprehensive or accurate discrimination between them. Currently, untargeted metabolomics, combined with multivariate statistical methods such as principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA), are widely used to profile diverse classes of metabolites and to better understand the chemical diversity and the multiple pharmacological effects of ginsenosides or ginseng \[[@B10-molecules-24-00033],[@B11-molecules-24-00033]\]. Given the multi-component property, the combination of LC-MS-based metabolomic profiling with multivariate statistical analysis methods was used as a rapid means of characterization and was increasingly applied for analyzing ginseng from different herbs, cultivation environments/areas, cultivation ages or different parts \[[@B12-molecules-24-00033],[@B13-molecules-24-00033]\]. As an example, for different herbs belonging to the same genus, specific biomarkers including chikusetsusaponin IVa, ginsenoside Rf and ginsenoside Rc were selected and verified for ginseng \[[@B14-molecules-24-00033]\]. In another example of different parts analysis, the metabolic profiles of root, leaf, flower bud, berry and seed of ginseng were investigated \[[@B12-molecules-24-00033],[@B15-molecules-24-00033]\]. In addition, the approach for the discrimination of different red ginseng root parts was reported. As a result, fine roots had the highest protopanaxadiol (PPD)/protopanaxatriol (PPT) ratio, which could clearly distinguish the main roots from the lateral roots and fine roots parts \[[@B16-molecules-24-00033]\]. Such analysis was also applied to make metabolite profiling and age discrimination of 4- and 6-year- old red ginseng \[[@B17-molecules-24-00033]\], or 1--6 years ginseng \[[@B18-molecules-24-00033]\].

In addition, UNIFI, the automated data processing software, is an integrated informatics platform that possesses the ability to incorporate scientific library into a streamlined workflow, aiming at identifying chemical components from complex raw data \[[@B19-molecules-24-00033]\]. The combination of UPLC separation, Q/TOF-MS detection and UNIFI platform has been frequently applied in the characterization of chemical constituents of herbs \[[@B20-molecules-24-00033],[@B21-molecules-24-00033]\].

Normally, CG is harvested after a 4--6 years cultivation period, and MCG is collected at ages of 10--20 years. To develop a more direct and more efficient discrimination method for the cultivation ages and to explore potential age-dependent markers, we chose 4, 5, 6-year-old CG and 12, 20-year-old MCG as the analytical samples in the present study. UPLC-QTOF-MS^E^, UNIFI platform and multivariate statistical analysis were then used to profile these two kinds of ginseng. The aims were to systematically screen the chemical components and to perform the non-targeted metabolomic analysis, and in turn will lay the foundation for the establishment of CG and MCG quality criteria in the future. In one hand, this study will reveal the structural diversity of secondary metabolites and the different patterns in CG and MCG. In the other hand, the present study could provide a reference point for a reliable, accurate method for distinguishing among CG and MCG samples of different ages.

2. Materials and Methods {#sec2-molecules-24-00033}
========================

2.1. Materials and Reagents {#sec2dot1-molecules-24-00033}
---------------------------

A total of 40 batches of CG and MCG root products, including 24 batches of CGs and 16 batches of MCGs, were collected from different cultivation areas in Jilin Province, the main source of ginseng in China. A detailed sample list is given in [Table 1](#molecules-24-00033-t001){ref-type="table"}. All samples were harvested and collected by Professor Li Ping-ya from Jilin University Institute of Frontier Medical Science, according to China Pharmacopoeia (2015 version) \[[@B22-molecules-24-00033]\]. Voucher specimens have been deposited at the Research Center of Nature Drug, School of Pharmaceutical Sciences, Jilin University, Changchun, China.

Acetonitrile, methanol were all UPLC-MS pure grade (Fisher Scientific Inc., Geel, Belgium). Formic acid (MS grade) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Leucine enkephaline was provided by Waters (Waters Technologies, Milford, MA., USA). Distilled water was prepared in-house via a Millipore water purification system (Millipore, Billerica, MA, USA). All other chemicals were analytical grade. For reference substances, ginsenoside F~1~ (R20151040), -F~2~ (R20151040), notoginsenoside R~1~ (R20170210), notoginseno- side R~4~ (R20170212) were provided by the Research Center of Natural Drugs, School of Pharmaceutical Sciences, Jilin University, China. Ginsenoside Rb~1~, -Rb~2~, -Rb~3~, -Rc, -Rd, -Re, -Rf, -F~5~, -Rg~1~, 20(*R*)-Rg~2~, 20(*S*)-Rh~1~, 20(*R*)-Rh~1~, 20(*S*)-Rg~3~, 20(*R*)-Rg~3~, -Ro, gypenoside XVII, ginsenoside Rs~1~, -Rs~2~ were isolated in our laboratory and identified by spectroscopic data. Adenine (101774299), tryptophane (73-22-2), palmitoleic acid (101491588) were purchased from Sigma-Aldrich. Notoginsenoside Fe (8105-29-5), D-adenosine (110879- 200502), histidine (624-200304) were purchased from the National Institutes for Food and Drug Control. Ginsenoside Rg~5~ (wkq16051002, Victory Biological Technology Co., Ltd., Sichuan, China), α-linoleic acid (B21469; Yuanye Biological Technology Co., Ltd., Shanghai, China), D-arginin (130701; Nuoye Biological Engineering Co., Ltd., Anhui, China) and phenylpropionic acid (A20160211), quillaic acid (A20171109) were purchased from Beijing Zhongke Quality Inspection Biotechnology Co., Ltd. (Beijing, China) with the Chinese National Standard Sieve No. 3 (R40/3 series).

2.2. Sample Preparation and Extraction {#sec2dot2-molecules-24-00033}
--------------------------------------

All the CG and MCG samples were air-dried, grinded (Baijie Stainless Steel Grinder, BJ-800A, Deqing Baijie Electric Apllicance Co. Ltd., Zhejiang, China) and sieved (Chinese National Standard Sieve No. 3, R40/3 series) to get the homogeneous powder respectively. Then, the powder of 40 samples (200 mg accurately weighed per sample) were refluxed respectively with 85% methanol (2 L) at 80 °C for three times (2 h, 2 h, 1 h each time, respectively). Then, the extracts of each sample were combined, concentrated and evaporated to dryness. Each powder was dissolved in 5.0 mL of 80% methonal. After being filtered, each methanolic solution was injected directly into UPLC system. Meanwhile, 20 μL aliquots of each CG and MCG sample were mixed to obtain a quality control (QC) sample, which contained all of the components in the analysis. The QC sample was run randomly to monitor the stability of the system. All of the above solutions were stored at 4 °C prior to LC-MS analysis and the injection volume was 2 μL.

2.3. UPLC/QTOF-MS^E^ {#sec2dot3-molecules-24-00033}
--------------------

The chromatographic separation and mass spectrometry detection were conducted on the Waters Acquity UPLC system coupled with a Xevo G2-S QTOF mass spectrometer equipped with an electrospray ionization source (ESI). Separation was performed on Waters ACQUITY UPLC BEH C~18~ column (100 mm × 2.1 mm, 1.7 μm) at 40 °C. The mobile phase consisted of eluent A (0.1% formic acid aqueous solution) and eluent B (0.1% formic acid in acetonitrile) at flow rate of 0.4 mL/min with the following gradient program: 0\~2 min, 10% (B); 2\~26 min, 10%\~100% (B); 26\~28 min, 100% (B); 28\~28.1 min, 100%\~10% (B); 28.1\~30 min, 10% (B). Mixtures of 10/90 and 90/10 water/acetonitrile were the strong wash and the weak wash solvent, respectively. The optimized conditions were employed: source temperature was 120 °C, the desolvation temperature was 300 °C, capillary voltage was 2.6 kV(ESI^+^) or 2.2 kV (ESI^−^), cone voltage was 40 V, desolvation gas flow was 800.0 L/h, cone gas flow was 50 L/h. The energy of low energy function and the collision energy of high energy function were set at 6 V and 20 V\~40 V respectively in MS^E^ mode. The mass spectrometer was calibrated with sodium formate in the range of 200--1500 Da. The lockmass compound used was leucine- enkephaline (external reference to the ion *m*/*z* 556.2771 in positive mode and 554.2615 in negative mode). Data were collected with Masslynx™ V4.1 workstation in continuum mode.

2.4. Chemical Information Database for the Components of CG and MCG {#sec2dot4-molecules-24-00033}
-------------------------------------------------------------------

In addition to the Waters Traditional Medicine Library in UNIFI software, a systematic investigation of chemical constituents from the target herbs based on the literature was conducted. A self-built database of compounds, such as saponins, flavonoids, volatile oil, amino acids and so on, isolated from CG and MCG was established by searching online databases such as China Journals of Full-Text Database (CNKI), PubMed, Medicine, Web of Science and ChemSpider. The name, molecular formula and structure of components from CG and MCG were obtained in the database.

2.5. The Screening Analysis Based on UNIFI Platform {#sec2dot5-molecules-24-00033}
---------------------------------------------------

UNIFI 1.7.0 software (Waters, Manchester, UK) was used to perform the screening analysis on the structural characteristics and MS fragmentation behaviors, especially for characteristic fragments. Main parameters were set as follows: peak intensity of high energy over 200 counts and the peak intensity of low energy over 1000 counts were the selected parameters in peak detection; mass error up to ±10 ppm for identified compound; retention time tolerance was set in the range of ±0.1 min; positive adducts containing +H, +Na or negative adducts containing −H, +HCOOH were all selected; the reference compound was leucine-enkephalin (556.2766 for positive ion, 554.2620 for negative ion). The MS raw data were processed using the streamlined workflow of UNIFI software to quickly identify the chemical components that met the match criteria with the in-house Traditional Medicine Library and the self-built database \[[@B20-molecules-24-00033],[@B21-molecules-24-00033]\].

2.6. The Metabolomics Analysis Based on Multivariate Statistical Analysis {#sec2dot6-molecules-24-00033}
-------------------------------------------------------------------------

To differentiate MCG and CG, MarkerLynx XS V4.1 software (Waters, Milford, DE, USA) was used to process the raw data by deconvolution, alignment, data reduction and to perform the multivariate statistical analysis \[[@B20-molecules-24-00033],[@B21-molecules-24-00033]\]. The following steps were performed: acquiring data, creating a MarkerLynx processing method, processing the acquired data and viewing results Extended Statistics (XS) Viewer. The main parameters in the method set to process the raw data were as follows: retention time range 5--28 min, mass range 200--1400 Da, mass tolerance 5 mDa, intensity threshold 2000 counts, mass window 0.05 Da, retention time window 0.20 min. In resulting database list, RT-*m*/*z* pairs represent an identifier of ion in the order of their elution time. The same value of RT and *m*/*z* in different batches of samples were regarded as the same compound. Multivariate statistical analysis was then performed to find the potential biomarkers that significantly contributed to the difference among the groups. During the analysis, principal component analysis (PCA) was firstly used to show the maximum variation and pattern recognition in order to get the overview and classification, and the orthogonal projections to latent structures discriminant analysis (OPLS-DA) was then performed aiming to get the maximum separation between two groups. S-plots was then available to provide visualization of the OPLS-DA predictive component loading to facilitate model interpretation. Variable importance for the projection (VIP) was also used to help screen the different components, and the metabolites with VIP value above 1.0 were considered as potential markers. Additionally, a permutation test was performed to provide reference distributions of the R^2^/Q^2^-values that could indicate the statistical significance. Simca 15.0 software (Umetrics, Malmö, Sweden) was used to show the analysis results.

3. Results and Discussion {#sec3-molecules-24-00033}
=========================

3.1. Identification of Components from MCG and CG Based on UNIFI Platform {#sec3dot1-molecules-24-00033}
-------------------------------------------------------------------------

As a result of our analysis, a total of 126 compounds, including triterpenoids (the main ingredients), flavonoids, organic acids and organic acid esters, alcohol phenols, aldehyde ketones and amino acids, etc., were characterized or tentatively identified from the MCG and CG in both ESI^+^ and ESI^−^ modes. 85 compounds were identified in ESI^+^ mode and 41 compounds were identified in ESI^-^ mode. Base peak intensity (BPI) chromatograms are shown in [Figure 1](#molecules-24-00033-f001){ref-type="fig"}, the identification information is listed in [Table 2](#molecules-24-00033-t002){ref-type="table"}, and the chemical structures are shown in [Figure 2](#molecules-24-00033-f002){ref-type="fig"}.

For the isomers, they could be compared with the retention time of the standards or distinguished by the characteristic MS fragmentation patterns reported in literature. Taking compounds **82** and **88** as example, both of them had the same protonated ion \[M + HCOO\]^−^ at *m*/*z* 991.5464 and 991.5476. In a result, one of them was identified as ginsenoside Rd due to the same retention time, and the other one was tentatively identified as gypenoside XVII because it was matched with the characteristic MS fragmentation pattern of gypenoside XVII reported in the literature \[[@B31-molecules-24-00033]\].

3.2. Biomarker Discovery for Distinguishing MCG and CG {#sec3dot2-molecules-24-00033}
------------------------------------------------------

The MS^E^ data of CG and MCG samples were statistically analyzed via PCA and OPLS-DA. As seen in PCA 2D plots ([Figure 3](#molecules-24-00033-f003){ref-type="fig"}), there was no obvious difference among of 4--6-year-old CG samples, but the MCG~20\ years~, MCG~12\ years~ and CG~4--6\ years~ groups were obviously separated, indicating that these three groups could be differentiated. With the aim of distinguishing MCG from CG, or MCG~20\ years~ from MCG~12\ years~, OPLS-DA plot, permutation test, and S-plot, VIP values were obtained to understand which variables were responsible for the separation ([Figure 4](#molecules-24-00033-f004){ref-type="fig"}, [Figure 5](#molecules-24-00033-f005){ref-type="fig"} and [Figure 6](#molecules-24-00033-f006){ref-type="fig"}). The variables showing VIP \> 1 and *p* \< 0.05 (in *t*-test) were considered as potential biomarkers. The robust known biomarkers enabling the differentiation between CG and MCG were discovered and marked in S-plots. In order to systematically evaluate the biomarkers, heatmaps ([Figure 7](#molecules-24-00033-f007){ref-type="fig"}) were generated from these biomarkers. The hierarchical clustering heatmaps, intuitively visualizing the differential levels of potential biomarkers concentration in different ginseng groups, are shown in [Figure 7](#molecules-24-00033-f007){ref-type="fig"}. The larger contents were represented by red squares and smaller values by green squares.

Between the CG~4--6\ years~ and MCG~12\ years~ groups, the contents of 24-hydroxyoleanolic acid, ginsenoside F~3~ and palmitoleic acid in MCG~12~ samples were significantly higher. While, the contents of α-linolenic acid, 9-octadecenoic acid, linoleic acid and panaxydol in all the CG samples were significantly higher.

Between the CG~4--6\ years~ and MCG~20\ years~ groups, the contents of ginsenoside Re~1~, -Re~2~, -Rs~1~, malonylginsenoside Rb~2~, -Rf, isomer of malonylginsenoside-Rb~1~ and quinquenoside R~1~ in the samples of MCG~20\ years~ were higher. On the contrary, the contents of ginsenoside Ro and the isomer of ginsenoside Ro, 12,13,15-trihydroxy-9-octadecenoic acid, linoleic acid, 9-octadecenoic acid, α-linolenic acid, panaxydol were rather higher in CG samples.

Between the MCG~12\ years~ and MCG~20\ years~ groups, the contents of palmitoleic acid and 24-hydroxyoleanolic acid in MCG~12\ years~ samples were significantly high, while the contents of ginsenoside Re~1~, -Rs~1~, malonylginsenoside Rb~2~, -Re~2~ and isomer of malonylginsenoside Rb~1~ were rather higher in MCG~20\ years~ samples.

Overall, on one hand, the contents of α-linolenic acid, linoleic acid, 9-octadecenoic acid and panaxydol in CG samples were significantly higher than those in all MCG samples. On the other hand, ginsenoside Re~1~, -Re~2~, -Rs~1~, malonylginsenoside Rb~2~ and isomer of malonylginsenoside Rb~1~ in MCG~20\ years~ samples were really higher than those both in MCG~12\ years~ and in all of CG samples, but there is no significant difference between MCG~12\ years~ and CG~4--6\ years~ samples. The summary with variable identity, VIP and *p* value were shown in [Table 3](#molecules-24-00033-t003){ref-type="table"}.

4. Discussion {#sec4-molecules-24-00033}
=============

Although MCG and CG both belong to *Panax ginseng,* their chemical ingredients and pharmacological activities are different due to their significantly different growth environment \[[@B3-molecules-24-00033],[@B67-molecules-24-00033]\]. As we all know, MCG has been regarded as a replacement of wild ginseng. Recently, the UPLC-QTOF-MS/MS-based approach has been developed to distinguish MCG (grown for 15 years) and CG (grown for 4--7 years) \[[@B6-molecules-24-00033]\]. As a result, 40 ginsenosides in both MCG and CG were unambiguously identified and tentatively assigned, and the potential chemical markers identifying different ginseng products were characterised \[[@B6-molecules-24-00033]\]. Additionally, the study on 6--18-year-old Mountain Cultivated Ginseng Leaves (MGL) samples showed that the MGL were obviously divided into three main groups according to different age brackets (6\~10, 11\~13 and 14\~18 years) \[[@B7-molecules-24-00033]\]. Although the sample of the study was the leaf of MCG, it could be indirectly speculated that the MCG roots with different cultivation ages are also different. In order to further systematically compare the similarities and differences at the chemical level between different ages of ginseng, especially to compare the younger or the older MCG, 4, 5, 6-year-old CG and 12, 20-year-old MCG were chosen as the analytical samples in the present study.

Firstly, based on UNIFI platform, intelligent and automatic workflows, the screening analysis of metabolites in different cultivation ages of ginseng were rapidly performed. As a result, a total of 126 compounds were characterized from CG~4--6\ years~, MCG~12\ years~ and MCG~20\ years~ samples. Among of them, ginsenosides were the main ingredients. Both CG and MCG had the similar chemical composition, but the components were variously distributed in CG and MCG samples at different contents. That means in CG and MCG, the secondary metabolites had the features of structural diversity and the different content patterns. As far as we know, this is the first time that the comprehensive screening analysis of MCG~12\ years~ and MCG~20\ years~ samples by using UPLC-QTOF-MS^E^ combined with UNIFI platform. It could provide the scientific data for clarifying the chemical composition of MCG.

Secondly, the combination of LC-MS based metabolomic profiling with multivariate statistical analysis method was used to profile the CG, MCG~12\ years~ and MCG~20\ years~ samples. A total of 17 potential age-dependent markers enabling differentiation among the CG and MCG samples were discovered. (1) There were four robust markers including α-linolenic acid, 9-octadecenoic acid, linoleic acid and panaxydol being the characteristic components for CG samples, that distinguished them from both MCG~12\ years~ and MCG~20\ years~ samples. The results showed that CG samples contained more non-ginsenosides. Both linoleic acid and α-linolenic acid, the main products of the acetate-malonate pathway, are two essential fatty acids necessary for health. Linoleic acid is used in the biosynthesis of arachidonic acid and thus some prostaglandins, leukotrienes, and thromboxane \[[@B68-molecules-24-00033],[@B69-molecules-24-00033]\]. Panaxydol, one of the C17 polyacetylenic compounds, originates from acetyl-CoA/malonyl-CoA via fatty acids with crepenynate as the intermediate \[[@B70-molecules-24-00033]\]. It is considered a potential antitumor agent due to its significant anticancer activity \[[@B71-molecules-24-00033]\]. (2) In CG samples, there were three other characteristic components such as ginsenoside Ro, the isomer of ginsenoside Ro, and 12,13,15-trihydroxy-9-octadecenoic acid, that could be used to differentiate them from MCG~20\ years~ samples. From this, we could draw a conclusion that pentacyclic triterpenoids decreased significantly in older MCG samples. (3) Five robust biomarkers including ginsenoside Re~1~, -Re~2~, -Rs~1~, malonylginsenoside Rb~2~ and isomer of malonylginsenoside Rb~1~ were found to enable differentiation of MCG~20\ years~ from CG and MCG~12\ years~ samples. These five compounds might be used for rapid identification of MCG~20\ years~ samples. A proposed biosynthetic pathway of ginsenosides is as follows: with the action of squalene epoxidase, squalene was converted to 2,3-oxidosqualene. Dammaranes can be synthesized by dammarenediol synthase, and oleananes by β-amyrin synthase \[[@B72-molecules-24-00033]\]. Ginsenosides were found to have both antimicrobial and antifungal properties and the molecules are naturally bitter-tasting, discouraging insects and other animals from consuming the plant, so ginsenosides likely serve as mechanisms for plant defense \[[@B73-molecules-24-00033],[@B74-molecules-24-00033]\]. (4) In MCG~20\ years~ samples, another two markers, ginsenoside Rf and quinquenoside R~1~, were discovered that distinguished them from all CG samples. (5) In MCG~12\ years~ samples, 24-hydroxyoleanolic acid and palmitoleic acid were the two robust markers for distinguished from both CG and MCG~20\ years~ samples. These two compounds might be used for rapid identification of MCG~12\ years~ samples. Palmitoleic acid is biosynthesized from palmitic acid by the action of the enzyme stearoyl-CoA desaturase-1, a key enzyme in fatty acid metabolism \[[@B75-molecules-24-00033]\]. (6) Ginsenoside F~3~ was another marker for MCG~12\ years~ samples that differentiated them from CG samples. However, there are still some unresolved issues. For example, as shown in BPI chromatograms, though 126 compounds were identified, there are still some unidentified components. there are still some unidentified components. Further research should be carried out based on the formula of these unknown compounds.

5. Conclusions {#sec5-molecules-24-00033}
==============

By combining the UPLC-Q/TOF-MS^E^ and UNIFI platform, 126 chemical components with various structural types, such as triterpenoids, flavonoids, organic acids and organic acid esters, etc., were characterized or tentatively identified from CG~4--6\ years~, MCG~12\ years~ and MCG~20\ years~ samples for the first time. All the CG and MCG samples had the similar chemical composition, but there were significant differences in the content of each component. Further nontarget metabolomic analysis combined with multivariate statistical analysis showed that CG~4--6\ years~, MCG~12\ years~ and MCG~20\ years~ samples were obviously divided into three different groups. A total of 17 potential age-dependent markers enabling differentiation among the CG and MCG samples were discovered. Among of these markers, four robust markers, including α-linolenic acid, 9-octadecenoic acid, linoleic acid and panaxydol, could be the characteristic components for differentiation of CG from all other MCG samples. Five robust markers including ginsenoside Re~1~, -Re~2~, -Rs~1~, malonylginsenoside Rb~2~ and isomer of malonylginsenoside Rb~1~ were found to enable differentiate MCG~20\ years~ samples from all other samples, while 24-hydroxyoleanolic acid and palmitoleic acid were the robust markers for distinguishing MCG~12\ years~ samples from all the CG samples and MCG~20\ years~ samples. The proposed approach could be applied to directly distinguish MCG root ages, which is an important criterion for evaluating the quality of MCG. The results will provide the data for the deficient study on the chemical constituents of MCG and provide reference for the quantitative determination in the quality control criterion of MCG.

**Sample Availability:** Samples of the compounds are available from the authors.
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![The representative BPI chromatograms of CG and MCG in positive and negative modes.](molecules-24-00033-g001){#molecules-24-00033-f001}

###### 

Chemical structures of compounds identified in MCG and CG.
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![The PCA of CG and MCG in positive mode (**A**) and negative mode (**B**).](molecules-24-00033-g003){#molecules-24-00033-f003}

![The OPLS-DA/Permutation test/S-Plot of CG~4--6\ years~ and MCG~12\ years~ in positive mode (**A**/**B**/**C**) and negative mode (**D**/**E**/**F**).](molecules-24-00033-g004){#molecules-24-00033-f004}

![The OPLS-DA/Permutation test/S-Plot of CG~4--6\ years~ and MCG~20\ years.~ in positive mode (**A**/**B**/**C**) and negative mode (**D**/**E**/**F**).](molecules-24-00033-g005){#molecules-24-00033-f005}

![The OPLS-DA/Permutation test/S-Plot of MCG~12\ years~ and MCG~20\ years~ in positive mode (**A**/**B**/**C**) and negative mode (**D**/**E**/**F**).](molecules-24-00033-g006){#molecules-24-00033-f006}

![The heatmaps visualizing the intensities of potential biomarkers.](molecules-24-00033-g007){#molecules-24-00033-f007}

molecules-24-00033-t001_Table 1

###### 

Details of the MCG and CG samples.

  Sample No.                                                                                                                                           Source                                  Collection Time
  ---------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------- ------------------
  CG~3years~-1, CG~3years~-2; CG~4years~-1, CG~4years~-2; CG~5years~-1, CG~5years~-2; MCG~12years~-1, MCG~12years~-2; MCG~20years~-1, MCG~20years~-2   Ji′an City, Jilin Province, China       2017.09--2017.10
  CG~3years~-3, CG~3years~-4; CG~4years~-3, CG~4years~-4; CG~5years~-3, CG~5years~-4; MCG~12years~-3, MCG~12years~-4; MCG~20years~-3, MCG~20years~-4   Fusong County, Jilin Province, China    2017.09--2017.10
  CG~3years~-5, CG~3years~-6; CG~4years~-5, CG~4years~-6; CG~5years~-5, CG~5years~-6; MCG~12years~-5, MCG~12years~-6; MCG~20years~-5, MCG~20years~-6   Tonghua City, Jilin Province, China     2017.09--2017.10
  CG~3years~-7, CG~3years~-8; CG~4years~-7, CG~4yeasr~-8; CG~5years~-7, CG~5years~-8; MCG~12years~-7, MCG~12years~-8; MCG~20years~-7, MCG~20years~-8   Jingyu Country, Jilin Province, China   2017.09--2017.10

molecules-24-00033-t002_Table 2

###### 

Compounds identified from MCG and CG by UPLC-QTOF-MS^E^.

  No.   t~R~ (min)   Formula              Calculated Mass (Da)   Theoretical Mass (Da)   Mass Error (ppm)   MS^E^ Fragmentation                                                                                                                                                                                                                            Identification                                       Sources                            Ref.
  ----- ------------ -------------------- ---------------------- ----------------------- ------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------- ---------------------------------- -------------------------------
  1     0.49         C~5~H~8~N~2~O~5~     176.0431               176.0433                −1.5               177.0503\[M + H\]^+^; 130.0495\[M -- 2 × OH − NH~2~\]^+^                                                                                                                                                                                       Dencichine                                           CG, MCG~12~, MCG~20~               \[[@B23-molecules-24-00033]\]
  2     0.54         C~6~H~14~N~4~O~2~    174.1115               174.1117                −1.1               175.1188\[M + H\]^+^;158.0912\[M − NH~2~\]^+^; 116.0704\[M − NH~2~ − CN~2~H~2~\]^+^;114.1015\[M − NH~2~ − CHO~2~\]^+^                                                                                                                          Adipodihydrazide                                     CG, MCG~12~, MCG~20~               a
  3     0.55         C~30~H~22~O~10~      542.1257               542.1213                8.1                543.1330\[M + H\]^+^; 273.0833\[M − C~15~H~10~O~5~\]^+^; 242.1025\[M − OH − C~15~H~10~O~6~\]^+^; 127.0388\[M − C~24~H~17~O~7~\]^+^; 116.0703\[M − 2 × OH − C~21~H~12~O~8~\]^+^; 109.0284\[M − C~24~H~15~O~8~\]^+^                              Chamaejasmine                                        CG, MCG~12~, MCG~20~               a
  4     0.59         C~12~H~22~O~11~      342.1156               342.1162                −1.6               365.1055\[M + Na\]^+^; 203.0550\[M − OH − C~4~H~8~O~4~\]^+^; 185.0444\[M − 2 × OH − C~4~H~8~O~4~\]^+^                                                                                                                                          α-Maltose                                            CG, MCG~12~, MCG~20~               \[[@B24-molecules-24-00033]\]
  5     0.69         C~6~H~14~N~4~O~2~    174.1115               174.1117                −0.9               175.1188\[M + H\]^+^                                                                                                                                                                                                                           [d]{.smallcaps}-Arginin                              CG, MCG~12~, MCG~20~               s
  6     0.74         C~19~H~18~O~11~      422.0842               422.0849                −1.7               423.0915\[M + H\]^+^; 268.1040\[M + H − C~6~H~6~O~5~\]^+^; 119.0349\[M − C~15~H~10~O~7~\]^+^                                                                                                                                                   Isomangiferin                                        CG, MCG~12~, MCG~20~               \[[@B25-molecules-24-00033]\]
  7     0.75         C~5~H~5~N~5~         135.0546               135.0545                0.5                136.0618\[M + H\]^+^; 119.0352\[M − NH~2~\]^+^                                                                                                                                                                                                 Adenine                                              CG, MCG~12~, MCG~20~               s
  8     0.76         C~10~H~13~N~5~O~4~   267.0974               267.0968                2.4                268.1050\[M + H\]^+^; 136.0618\[M − C~5~H~9~O~4~\]^+^; 119.0352\[M − C~5~H~9~O~4~ − NH~2~\]^+^                                                                                                                                                 [d]{.smallcaps}-Adenosine                            CG, MCG~12~, MCG~20~               s
  9     0.80         C~20~H~15~NO~6~      365.0876               365.0899                −6.3               366.0949\[M + H\]^+^                                                                                                                                                                                                                           Integriamide                                         CG, MCG~12~, MCG~20~               a
  10    0.81         C~25~H~30~O~12~      538.1677               538.1686                −1.7               561.1569\[M + Na\]^+^; 393.1138\[M − C~6~H~8~O~4~\]^+^; 381.0788\[M − CH~3~ − C~7~H~10~O~3~\]^+^; 366.0930\[M − OH − C~8~H~10~O~3~\]^+^; 366.0930\[M − C~19~H~21~O~8~\]^+^                                                                     Linearoside                                          CG, MCG~12~, MCG~20~               \[[@B26-molecules-24-00033]\]
  11    0.82         C~9~H~11~NO~2~       165.0782               165.0790                −0.5               166.0862\[M + H\]^+^; 120.0805\[M − COOH\]^+^~;~ 103.0543\[M − COOH − NH~2~\]^+^                                                                                                                                                               Phenylpropionic acid                                 CG, MCG~12~, MCG~20~               s
  12    0.91         C~6~H~9~N~3~O~2~     155.0762               155.0695                −3.5               156.0762\[M + H\]^+^                                                                                                                                                                                                                           Histidine                                            CG, MCG~12~, MCG~20~               s
  13    1.05         C~11~H~12~N~2~O~2~   204.0898               204.0899                −0.5               205.0971\[M + H\]^+^; 188.0706\[M − NH~2~\]^+^; 143.0723\[M − NH~2~ − COOH\]^+^; 118.0649\[M − NH~2~ − COOH − C~2~H~3~\]^+^                                                                                                                    Tryptophan                                           CG, MCG~12~, MCG~20~               s
  14    1.06         C~6~H~14~N~4~O~2~    174.1117               174.1117                0.0                175.1190\[M + H\]^+^                                                                                                                                                                                                                           Argentine                                            CG, MCG~12~, MCG~20~               \[[@B27-molecules-24-00033]\]
  15    3.13         C~25~H~28~O~4~       392.2009               392.1988                5.5                393.2082\[M + H\]^+^                                                                                                                                                                                                                           Glabrol                                              CG, MCG~12~, MCG~20~               \[[@B28-molecules-24-00033]\]
  16    3.27         C~25~H~24~O~5~       404.1646               404.1624                5.1                405.1719\[M + H\]^+^                                                                                                                                                                                                                           Puerarol                                             CG, MCG~12~, MCG~20~               \[[@B29-molecules-24-00033]\]
  17    4.42         C~27~H~38~O~6~       458.2716               458.2668                10.0               481.2609\[M + Na\]^+^~;~ 436.2642\[M − COOH\]^+^                                                                                                                                                                                               Lucideric acid                                       CG, MCG~12~, MCG~20~               a
  18    4.64         C~36~H~58~O~8~       618.4107               618.4132                −4.0               619.4180\[M + H\]^+^; 421.3446\[M − Glc − OH\]^+^                                                                                                                                                                                              β-[d]{.smallcaps}-Glcopyranosyl oleanolate           CG, MCG~12~, MCG~20~               \[[@B30-molecules-24-00033]\]
  19    4.89         C~48~H~82~O~19~      962.5484               962.5450                3.3                985.5312\[M + Na\]^+^; 765.4795\[M − Glc − OH\]^+^; 541.2637\[M − Glc − OH − C~15~H~28~O\]^+^; 421.3463\[M − Glc − Glc/Rha − 2 × OH\]^+^                                                                                                       Majoroside F6                                        CG, MCG~12~, MCG~20~               \[[@B31-molecules-24-00033]\]
  20    5.21         C~31~H~46~O~8~       546.3248               546.3193                9.7                569.3140\[M + Na\]^+^; 133.0859\[M − C~25~H~33~O~5~\]^+^                                                                                                                                                                                       Methyl ganoderate G                                  CG, MCG~12~, MCG~20~               a
  21    5.53         C~35~H~48~O~9~       612.3344               612.3298                7.4                613.3416\[M + H\]^+^~;~ 582.3264\[M − OCH~3~\]^+^~;~ 526.2986\[M − C~4~H~7~O~2~\]^+^                                                                                                                                                           Cinobufagin 3-hemisuberate methyl ester              CG, MCG~12~, MCG~20~               a
  22    5.56         C~45~H~74~O~17~      886.4877               886.4926                −5.4               909.4769\[M + Na\]^+^; 745.4383\[M − CH~2~OH − C~6~H~10~O~2~\]^+^; 729.4136\[M − OH − C~8~H~14~O~2~\]^+^; 601.2768\[M − 2 × OH − C~16~H~26~O~4~\]^+^; 431.1870\[M − Glc − C~19~H~27~O~2~\]^+^                                                  Shatavarin IV                                        CG, MCG~12~, MCG~20~               \[[@B32-molecules-24-00033]\]
  23    5.64         C~25~H~32~O~13~      540.1800               540.1843                3.0                541.1873\[M + H\]^+^; 347.0906\[M − CH~3~O − C~2~H~4~ − C~8~H~9~O~2~\]^+^; 195.1008\[M − Glc − C~2~H~4~O~2~ − C~6~H~5~O~2~\]^+^                                                                                                                Oleuropein                                           CG, MCG~12~, MCG~20~               \[[@B33-molecules-24-00033]\]
  24    5.65         C~14~H~16~O~4~       248.1025               248.1049                −9.7               271.0917\[M + Na\]^+^; 195.1008\[M − C~2~H~4~ − COH\]^+^; 189.1348\[M − OH − COOH\]^+^                                                                                                                                                         Isohistiopterosin A                                  CG, MCG~12~, MCG~20~               a
  25    5.79         C~45~H~74~O~17~      886.4881               886.4926                −5.0               909.4773\[M + Na\]^+^; 707.4360\[M − Glc\]^+^; 689.4262\[M − Glc − OH\]^+^; 657.3636\[M − Glc − OH − 2 × CH~3~\]^+^; 609.3646\[M − Glc − C~6~H~10~O~2~\]^+^; 523.3626\[M − Glc/Glc − C~3~H~6~\]^+^                                             Malonylginsenoside Rf                                CG, MCG~12~, ^\#\#^ MCG~20~        \[[@B34-molecules-24-00033]\]
  26    6.21         C~42~H~70~O~14~      798.4778               798.4766                1.6                799.4851\[M + H\]^+^; 439.3563\[M − Glc/Rha − 2 × OH\]^+^; 421.3441\[M − Glc/Rha − 3 × OH − H~2~O\]^+^                                                                                                                                         Ginsenoside Rg~8~                                    CG, MCG~12~, MCG~20~               \[[@B34-molecules-24-00033]\]
  27    6.23         C~22~H~32~O~13~      504.1840               504.1843                −0.6               503.1767\[M − H\]^−^; 457.1715\[M − OH − CH~2~OH\]^−^; 293.0878\[M − C~2~H~4~O − CH~2~OH − C~8~H~9~O~2~\]^−^                                                                                                                                   Cistanoside H                                        CG, MCG~12~, MCG~20~               \[[@B35-molecules-24-00033]\]
  28    6.24         C~23~H~28~O~11~      480.1594               480.1632                −7.7               481.1667\[M + H\]^+^; 317.0803\[M − C~10~H~12~O~2~\]^+^                                                                                                                                                                                        Peoniflorin                                          CG, MCG~12~, MCG~20~               a
  29    6.28         C~24~H~30~O~12~      510.1702               510.1737                −6.9               511.1775\[M + H\]^+^; 317.0803\[M − C~11~H~14~O~3~\]^+^                                                                                                                                                                                        Mudanpioside D                                       CG, MCG~12~, MCG~20~               \[[@B36-molecules-24-00033]\]
  30    6.39         C~54~H~92~O~24~      1124.5943              1124.5978               −3.1               1147.5835\[M + Na\]^+^; 585.2870\[M − C~25~H~47~O~12~\]^+^; 325.1130\[M − C~42~H~71~O~14~\]^+^                                                                                                                                                 Ginsenoside V                                        CG, MCG~12~, MCG~20~               \[[@B31-molecules-24-00033]\]
  31    6.49         C~48~H~82~O~19~      962.5484               962.5450                3.3                985.5302\[M + Na\]^+^; 865.4789\[M − C~6~H~9~O\]^+^; 823.4787\[M − C~8~H~11~O~2~\]^+^; 805.4668\[M − C~8~H~13~O~3~\]^+^; 555.2763\[M − C~12~H~26~O~5~\]^+^; 423.3602\[M − Glc − Glc/Glc − OH\]^+^; 405.3507\[M − Glc − Glc/Glc − 2 × OH\]^+^   Ginsenoside Re~1~                                    CG, MCG~12~, ^\#\#,^\* MCG~20~     \[[@B37-molecules-24-00033]\]
  32    6.59         C~23~H~28~O~11~      480.1587               480.1632                −9.3               481.1660\[M + H\]^+^; 317.0810\[M − C~7~H~5~O − C~3~H~5~O\]^+^                                                                                                                                                                                 Mudanpioside I                                       CG, MCG~12~, MCG~20~               \[[@B38-molecules-24-00033]\]
  33    6.64         C~41~H~70~O~14~      786.4762               786.4766                −0.4               831.4744\[M + HCOO\]^−^; 653.4270\[M − H − C~5~H~8~O~4~\]^−^, 491.3710\[M − H − C~11~H~18~O~9~\]^−^                                                                                                                                            Notoginsenoside Rw2                                  CG, MCG~12~, MCG~20~               \[[@B39-molecules-24-00033]\]
  34    6.67         C~47~H~80~O~18~      932.5335               932.5345                −1.0               977.5317\[M + HCOO\]^−^; 785.4693\[M − Ara − CH~3~\]^−^;653.4282\[M − Glc − 2 × OH − C~5~H~9~\]^−^                                                                                                                                             Quinquenoside F~6~                                   CG, MCG~12~, MCG~20~               \[[@B37-molecules-24-00033]\]
  35    6.77         C~36~H~60~O~9~       636.4217               636.4237                −3.1               637.4290\[M + H\]^+^; 621.42740\[M − OH\]^+^; 423.3605\[M − Glc − 2 × OH\]^+^                                                                                                                                                                  Ginsenoside Rh~8~                                    CG, MCG~12~, MCG~20~               \[[@B40-molecules-24-00033]\]
  36    6.84         C~48~H~82~O~19~      962.5469               962.5450                1.9                1007.5456\[M + HCOO\]^−^; 799.4848\[M − Glc\]^−^; 637.4317\[M − Glc/Glc\]^−^; 179.0545\[Glc − H\]^−^                                                                                                                                           20-β-[d]{.smallcaps}-Glucopyranosyl-ginsenoside Rf   CG, MCG~12~, MCG~20~               \[[@B41-molecules-24-00033]\]
  37    6.80         C~42~H~70~O~13~      782.4773               782.4816                −5.4               805.4665\[M + Na\]^+^; 765.4734\[M − OH\]^+^; 677.4220\[M − 2 × OH − C~4~H~7~O\]^+^; 661.4265\[M − 3 × OH − C~4~H~7~O\]^+^; 439.3562\[M − Glc − Man − OH\]^+^                                                                                  Ginsenoside Rh~14~                                   CG, MCG~12~, MCG~20~               \[[@B40-molecules-24-00033]\]
  38    6.82         C~17~H~24~O~8~       356.1460               356.1472                −3.1               379.1352\[M + Na\]^+^; 145.0495\[M − OH − C~11~H~13~O~3~\]^+^                                                                                                                                                                                  Erigeside II                                         CG, MCG~12~, MCG~20~               \[[@B42-molecules-24-00033]\]
  39    6.96         C~47~H~80~O~18~      932.5410               932.5345                6.7                977.5392\[M + HCOO\]^−^; 799.4825\[M − Xyl\]^−^; 769.4724\[M − H − Glc\]^−^; 637.4291\[M − (Glc/Xyl) \]^−^; 179.0539 \[Glc − H\]^−^                                                                                                            Notoginsenoside R~1~                                 CG, MCG~12~, MCG~20~               s
  40    6.99         C~28~H~44~O~12~      572.2810               572.2833                −3.9               573.2883\[M + H\]^+^; 555.2779\[M − OH\]^+^; 531.2860\[M − C~2~H~3~O\]^+^                                                                                                                                                                      Picrasinoside G                                      CG, MCG~12~, MCG~20~               a
  41    7.05         C~48~H~82~O~19~      962.5425               962.5450                −2.6               1007.5415\[M + HCOO\]^−^; 799.4822\[M − Glc\]^−^; 637.4333\[M − (Glc/Glc) \]^−^                                                                                                                                                                Notoginsenoside N                                    CG, MCG~12~, MCG~20~               \[[@B43-molecules-24-00033]\]
  42    7.20         C~48~H~82~O~19~      962.5422               962.5450                −2.9               985.5314\[M + Na\]^+^; 703.4371\[M − Glc − 2 × OH − CH~2~OH\]^−^; 439.3565\[M − Glc − Glc/Glc − OH\]^−^                                                                                                                                        Ginsenoside Re~2~                                    CG, MCG~12~, ^\#\#,^\*\*MCG~20~    \[[@B40-molecules-24-00033]\]
  43    7.34         C~42~H~72~O~14~      800.4934               800.4922                1.4                845.4916\[M + HCOO\]^−^; 637.4344\[M − Glc\]^−^; 475.3798\[M − Glc − Glc\]^−^; 179.0553\[Glc − H\]^−^;                                                                                                                                         Ginsenoside Rg~1~                                    CG, MCG~12~, MCG~20~               s
  44    7.36         C~48~H~82~O~18~      946.5524               946.5501                2.3                991.5506\[M + HCOO\]^−^; 783.4912\[M − Glc\]^−^; 637.4344\[M − (Glc/Rha)\]^−^; 475.3798\[M − Glc − (Glc/Rha)\]^−^                                                                                                                              Ginsenoside Re                                       CG, MCG~12~, MCG~20~               s
  45    7.74         C~45~H~74~O~17~      886.4925               886.4926                −0.1               885.4853\[M − H\]^−^; 781.4740\[M − HOCOCH~2~COOH\]^−^; 619.4197\[M − Glc(Mal)\]^−^; 161.0438\[Glc − H~2~O\]^−^                                                                                                                                Malonylginsenoside Rg~1~                             CG, MCG~12~, MCG~20~               \[[@B39-molecules-24-00033]\]
  46    7.93         C~48~H~76~O~19~      956.4960               956.4981                −2.2               979.4852\[M + Na\]^+^; 799.4161\[M − CO~2~ − CH~2~OH − C~6~H~12~\]^+^; 641.4008\[M − Glc − C~4~H~6~O~5~\]^+^;439.3562\[M − Glc − Glc/Glc(mal)\]^+^; 145.0493\[Glc − OH\]^+^                                                                    Isomer of ginsenoside Ro                             ^\#^ CG, MCG~12~, MCG~20~          \[[@B31-molecules-24-00033]\]
  47    8.04         C~51~H~84~O~21~      1032.5532              1032.5505               2.6                1031.5460\[M − H\]^−^; 987.5564\[M − CO~2~\]^−^; 927.5337\[M − HOCOCH~2~COOH\]^−^; 781.4759\[M − Rha(Mal) \]^−^; 619.4222\[M − (Rha(Mal)/Glc\]^−^                                                                                              Malonylginsenoside Re                                CG, MCG~12~, MCG~20~               \[[@B39-molecules-24-00033]\]
  48    8.08         C~48~H~76~O~19~      956.4950               956.4981                −3.1               979.4842\[M + Na\]^+^; 817.4311\[M − Glc\]^+^; 439.3571\[M − Glc/Glc − Glc − OH\]^+^                                                                                                                                                           Isomer of ginsenoside Ro                             CG, MCG~12~, MCG~20~               \[[@B44-molecules-24-00033]\]
  49    8.09         C~44~H~74~O~15~      842.5032               842.5028                0.5                841.4959\[M − H\]^−^; 799.4861\[M − CH~2~O\]^+^; 781.4741\[M − CH~2~O − OH\]^+^; 637.4316\[M − Xyl(mal)\]^+^; 619.4228\[M − Xyl(mal) − OH\]^+^; 475.3798\[M − Xyl(mal) − Glc\]^+^; 179.0550\[Glc − H\]^+^; 161.0439\[Glc − OH\]^+^             Yesanchinoside D                                     CG, MCG~12~, MCG~20~               \[[@B45-molecules-24-00033]\]
  50    8.10         C~45~H~74~O~17~      886.4931               886.4926                0.6                885.4858\[M − H\]^−^; 781.4741\[M − H − HOCOCH~2~COOH\]^−^; 619.4228\[M − H − Glc(Mal) \]^−^; 161.0439\[Glc − H − H~2~O\]^−^                                                                                                                   Isomer of malonylginsenoside Rg~1~                   CG, MCG~12~, MCG~20~               \[[@B39-molecules-24-00033]\]
  51    8.49         C~41~H~70~O~13~      770.4801               770.4816                −1.5               815.4784\[M + HCOO\]^−^; 637.4321\[M − Xyl\]^−^                                                                                                                                                                                                Notoginsenoside R~2~                                 CG, MCG~12~, MCG~20~               \[[@B39-molecules-24-00033]\]
  52    8.50         C~56~H~94~O~24~      1150.6124              1150.6135               −1.1               1149.6051\[M − H\]^−^; 1119.5951\[M − CH~2~OH − 2 × OH\]^−^; 807.4861\[M − Glc/Glc − OH\]^−^; 605.4423\[M − Glc/Glc − Glc(mal) \]^−^; 325.1119\[Glc/Glc − OH\]^−^                                                                              Quinquenoside R~1~                                   CG, MCG~12~, ^\#\#^ MCG~20~        \[[@B46-molecules-24-00033]\]
  53    8.60         C~22~H~30~O~47~      406.1957               406.1992                −8.5               407.2030\[M + H\]^+^; 376.1859\[M − OCH~3~\]^+^                                                                                                                                                                                                Nigakilactone K                                      CG, MCG~12~, MCG~20~               \[[@B47-molecules-24-00033]\]
  54    8.87         C~48~H~82~O~19~      962.5445               962.5450                −0.5               1007.5427\[M + HCOO\]^−^; 797.4706\[M − Glc\]^−^                                                                                                                                                                                               Ginsenoside Re~3~                                    CG, MCG~12~, MCG~20~               \[[@B37-molecules-24-00033]\]
  55    8.96         C~56~H~92~O~25~      1164.5929              1164.5928               0.1                1187.5821\[M + Na\]^+^; 1147.5803\[M − OH\]^+^; 805.4305\[M − Ara/Glc − CH~2~OH − CH~3~\]^+^; 443.3868\[M − Ara/Glc − Glc/Glc(mal)\]^+^                                                                                                        Malonylginsenoside Rb~2~                             CG, MCG~12~, ^\#\#,^\* MCG~20~     \[[@B44-molecules-24-00033]\]
  56    9.41         C~59~H~100~O~27~     1240.6488              1240.6452               2.8                1285.6740\[M + HCOO\]^−^; 945.5421\[M − (Ara/Xyl) \]^−^; 913.5184\[M − (Glc/Glc)\]^−^; 783.4900\[M − (Ara/Xyl) − Glc\]^−^                                                                                                                      Notoginsenoside R~4~                                 CG, MCG~12~, MCG~20~               s
  57    9.56         C~42~H~72~O~14~      800.4921               800.4922                −0.1               845.4903\[M + HCOO\]^−^; 637.4319\[M − Glc\]^−^; 475.3786\[M − (Glc/Glc)\]^−^; ^1,3^A~2β~221.0658; 161.0439\[Glc -- H − H~2~O\]^−^;^2,5^A~1β~101.0235                                                                                          Ginsenoside Rf                                       CG, MCG~12~, MCG~20~               s
  58    9.79         C~18~H~34~O~5~       330.2398               330.2406                −2.3               353.2290\[M + Na\]^+^; 213.1459\[M + H -- COOH -- C~5~H~11~\]^+^                                                                                                                                                                               12,13,15-Trihydroxy-9-octadecenoic acid              ^\#^ CG, MCG~12~, MCG~20~          \[[@B48-molecules-24-00033]\]
  59    9.87         C~41~H~70~O~13~      770.4809               770.4816                −1.0               815.4791\[M + HCOO\]^−^; 475.3783\[M − (Glc /Xyl)\]^−^; 161.0437\[Glc -- H -- H~2~O\]^−^                                                                                                                                                       Ginsenoside F~5~                                     CG, MCG~12~, MCG~20~               s
  60    9.89         C~60~H~102~O~28~     1270.6635              1270.6558               5.9                1315.6617\[M + HCOO\]^−^; 841.4991\[M − Glc/Glc -- OH -- C~4~H~4~\]^−^; 769.4777\[M − Glc/Glc/Glc -- CH~3~\]^−^                                                                                                                                Ginsenoside Ra~0~                                    CG, MCG~12~, MCG~20~               \[[@B49-molecules-24-00033]\]
  61    9.94         C~58~H~98~O~26~      1210.6358              1210.6346               1.0                1255.6340\[M + HCOO\]^−^; 1077.5833\[M -- Xyl\]^−^; 1047.5719\[M -- Glc\]^−^; 955.4871\[M -- Glc -- OH -- C~4~H~7~\]^−^; 783.4892\[M -- Glc/Xyl/Rha\]^−^                                                                                       Ginsenoside Ra~2~                                    CG, MCG~12~, MCG~20~               \[[@B50-molecules-24-00033]\]
  62    10.00        C~22~H~22~O~10~      446.1192               446.1213                −4.5               469.1084\[M + Na\]^+^; 429.1154\[M -- OH\]^+^; 385.0884\[M -- OH -- CH~3~ -- CH~2~OH\]^+^; 341.0661\[M -- C~4~H~8~O~3~\]^+^; 237.0746\[M -- C~10~H~13~O~5~\]^+^; 193.0483\[M -- C~12~H~16~O~6~\]^+^                                            Glycitin                                             CG, MCG~12~, MCG~20~               a
  63    10.01        C~59~H~100~O~27~     1240.6462              1240.6452               0.8                1285.6444\[M + HCOO\]^−^; 1107.5964\[M-Xyl\]^−^; 945.5424\[M -- (Glc/Xyl)\]^−^; 783.4912\[M -- Xyl -- GlcGlc\]^−^                                                                                                                              Notoginsenoside Fa                                   CG, MCG~12~, MCG~20~               \[[@B50-molecules-24-00033]\]
  64    10.05        C~54~H~92~O~23~      1108.6101              1108.6029               6.2                1153.6083\[M + HCOO\]^−^; 945.5437\[M -- Glc\]^−^; 783.4888\[M -- (Glc/Glc)\]^−^; 621.4382\[M -- (Glc/Glc) -- Glc\]^−^; 459.3835\[M -- (Glc/Glc) -- (Glc/Glc)\]^−^; ^2,5^A~1β~101.0235                                                         Ginsenoside Rb~1~                                    CG, MCG~12~, MCG~20~               s
  65    10.10        C~42~H~70~O~12~      766.4863               766.4867                −0.5               767.4936\[M + H\]^+^; 443.3866\[M -- Rha -- Glc\]^+^; 425.3762\[M -- Rha -- Glc -- OH\]^+^                                                                                                                                                     Ginsenoside Rg~4~                                    CG, MCG~12~, MCG~20~               \[[@B34-molecules-24-00033]\]
  66    10.20        C~57~H~94~O~26~      1194.6087              1194.6033               4.5                1193.6015\[M -- H\]^−^; 1149.6098\[M -- CO~2~\]^−^; 783.4908\[M -- Glc/Glc)\]^−^; 179.0545\[Glc -- H\]^−^                                                                                                                                      Isomer of malonylginsenoside Rb~1~                   CG, MCG~12~, ^\#\#,^\*\* MCG~20~   \[[@B39-molecules-24-00033]\]
  67    10.22        C~42~H~72~O~13~      784.4997               784.4973                2.9                829.4979\[M + HCOO\]^−^; 637.4336\[M − Rha\]^−^; 475.3809\[M -- (Glc/Rha)\]^−^; 161.0449 \[Rha -- H\]^−^                                                                                                                                       20(R)-Ginsenoside Rg~2~                              CG, MCG~12~, MCG~20~               s
  68    10.25        C~36~H~62~O~9~       638.4407               638.4394                2.9                683.4389\[M + HCOO\]^−^; 161.0449\[Glc − H − H~2~O\]^−^                                                                                                                                                                                        Ginsenoside Rh~1~                                    CG, MCG~12~, MCG~20~               s
  69    10.27        C~41~H~70~O~13~      770.4779               770.4816                −4.7               793.4672\[M + Na\]^+^; 587.4276\[M − Ara(p) − 2 × OH\]^+^; 423.3589\[M − Ara(p)/Glc − 2 × OH\]^+^                                                                                                                                              Ginsenoside F~3~                                     CG, ^∆∆^ MCG~12~, MCG~20~          \[[@B34-molecules-24-00033]\]
  70    10.29        C~36~H~60~O~8~       620.4292               620.4288                0.7                621.4365\[M + H\]^+^; 390.2277\[M − C~17~H~26~\]^+^; 187.1473\[M − OH − Glc − C~16~H~24~O\]^+^                                                                                                                                                 Ginsenoside Rh~4~                                    CG, MCG~12~, MCG~20~               \[[@B40-molecules-24-00033]\]
  71    10.32        C~53~H~90~O~22~      1078.5939              1078.5924               1.3                1101.5805\[M + Na\]^+^; 939.5312\[M − Glc\]^+^; 929.5452\[M − Ara(f)\]^+^; 789.4784\[M − Ara(f) − Glc\]^+^                                                                                                                                     Ginsenoside Rc                                       CG, MCG~12~, MCG~20~               s
  72    10.34        C~58~H~98~O~26~      1210.6356              1210.6346               0.7                1255.6338\[M + HCOO\]^−^; 1077.5851\[M − Xly\]^−^; 1047.5702\[M − Glc\]^−^; 945.5396\[M − (Xly/ Ara(p))\]^−^; 621.4323\[M − (Xly/ Ara(p)/Glc − Glc\]^−^                                                                                        Ginsenoside Ra~1~                                    CG, MCG~12~, MCG~20~               \[[@B50-molecules-24-00033]\]
  73    10.38        C~42~H~70~O~12~      766.4872               766.4867                0.6                767.4945\[M + H\]^+^;605.4423\[M − Glc\]^+^;443.3870\[M − Glc/Xyl\]^+^;407.3660\[M − Glc − 2 × OH\]^+^; 163.0591\[Glc − OH\]^+^;145.04901\[Glc − OH − H~2~O\]^+^                                                                               Ginsenoside Rg~5~                                    CG, MCG~12~, MCG~20~               s
  74    10.47        C~56~H~92~O~25~      1164.5947              1164.5928               1.6                1163.5874\[M − H\]^−^; 1119.5961\[M − CO~2~\]^−^; 927.5320\[M − Ara(f) − HOCOCH~2~COOH\]^−^                                                                                                                                                    Malonylginsenoside Rc                                CG, MCG~12~, MCG~20~               \[[@B44-molecules-24-00033]\]
  75    10.51        C~48~H~76~O~19~      956.5001               956.4981                2.1                955.4928\[M − H\]^−^; 793.4399\[M − Glc\]^−^; 613.3739\[M − Glc − Glc − OH\]^−^                                                                                                                                                                Ginsenoside Ro                                       ^\#^ CG, MCG~12~, MCG~20~          s
  76    10.57        C~57~H~94~O~26~      1194.6059              1194.6033               2.2                1193.5986\[M − H\]^−^; 1149.6062\[M − CO~2~\]^−^; 1089.5851\[M − HOCOCH~2~COOH\]^−^; 945.5428\[M − Glc(Mal)\]^−^; 783.4926\[M − (Glc/Glc)\]^−^                                                                                                 Malonylginsenoside Rb~1~                             CG, MCG~12~, MCG~20~               \[[@B39-molecules-24-00033]\]
  77    10.63        C~53~H~90~O~22~      1078.5979              1078.5924               4.9                1123.5961\[M + HCOO\]^−^; 945.5448\[M − Ara(p)\]^−^; 783.4896\[M − (Ara/Glc)\]^−^; 149.0443\[Ara(p) − H\]^−^                                                                                                                                   Ginsenoside Rb~2~/Rb~3~                              CG, MCG~12~, MCG~20~               s
  78    10.77        C~56~H~92~O~25~      1164.5986              1164.5928               5.0                1163.5913\[M − H\]^−^; 1101.5822\[M − CO~2~\]^−^; 765.4782\[M − H − Glc(Mal) − Ara(p) − OH\]^−^                                                                                                                                                Malonylginsenoside Rb~2~                             CG, MCG~12~, MCG~20~               \[[@B44-molecules-24-00033]\]
  79    11.06        C~36~H~62~O~9~       638.4391               638.4394                −0.4               683.4373\[M + HCOO\]^−^                                                                                                                                                                                                                        20(*R*)-Ginsenoside Rh~1~                            CG, MCG~12~, MCG~20~               s
  80    11.14        C~36~H~62~O~9~       638.4399               638.4394                0.7                661.4291\[M + Na\]^+^; 376.2462\[M − C~17~H~24~O~2~\]^+^                                                                                                                                                                                       Ginsenoside F~1~                                     CG, MCG~12~, MCG~20~               s
  81    11.15        C~56~H~92~O~25~      1164.5971              1164.5928               3.7                1163.5898\[M − H\]^−^; 1119.6000\[M − CO~2~\]^−^; 1059.5772\[M − H − C~3~H~4~O~4~\]^−^;                                                                                                                                                        Malonylginsenoside Rb~3~                             CG, MCG~12~, MCG~20~               \[[@B39-molecules-24-00033]\]
  82    11.27        C~48~H~82~O~18~      946.5482               946.5501                −1.9               991.5464\[M + HCOO\]^−^; 783.4878\[M − Glc\]^−^; 621.4350\[M − (Glc/Glc)\]^−^; 161.0435\[Glc − H\]^−^                                                                                                                                          Ginsenoside Rd                                       CG, MCG~12~, MCG~20~               s
  83    11.31        C~55~H~92~O~23~      1120.6049              1120.6029               1.7                1143.5941\[M + Na\]^+^; 831.4874\[M − Glc(mal)\]^−^                                                                                                                                                                                            Ginsenoside Rs~1~                                    CG, MCG~12~, ^\#\#,^\* MCG~20~     s
  84    11.36        C~42~H~70~O~12~      766.4875               766.4867                1.0                767.4947\[M + H\]^+^; 605.4423\[M − Rha\]^+^; 587.4300\[M − Rha − OH\]^+^; 569.4211\[M − Rha − 2 × OH\]^+^; 443.3866\[M − Rha/Glc\]^+^; 425.3769\[M − Rha/Glc − OH\]^+^; 145.0491\[Rha − H − H~2~O\]^+^                                        Ginsenoside Rg~6~                                    CG, MCG~12~, MCG~20~               \[[@B44-molecules-24-00033]\]
  85    11.42        C~51~H~84~O~21~      1032.5515              1032.5505               0.9                1131.5442\[M − H\]^−^; 765.4785\[M − Glc(mal) − OH\]^−^; 621.4372\[M − (Glc/Glc(mal)\]^−^                                                                                                                                                      Malonylginsenoside Rd                                CG, MCG~12~, MCG~20~               \[[@B45-molecules-24-00033]\]
  86    11.53        C~55~H~92~O~23~      1120.6065              1120.6029               3.0                1165.6047\[M + HCOO\]^−^; 1077.5851\[M − Ac\]^−^; 1059.5745\[M − Ac − OH\]^−^                                                                                                                                                                  Ginsenoside Rs~2~                                    CG, MCG~12~, MCG~20~               s
  87    11.69        C~42~H~70~O~13~      782.4738               782.4816                −9.7               805.4631\[M + Na\]^+^; 621.4354\[M − Glc\]^+^; 311.0902\[Glc/Glc − CH~2~OH\]^+^                                                                                                                                                                Ginsenoside Rg~10~                                   CG, MCG~12~, MCG~20~               a
  88    11.79        C~48~H~82~O~18~      946.5494               946.5501                −0.7               991.5476\[M + HCOO\]^−^; 927.5308\[M − OH\]^−^; 783.4926\[M − Glc\]^−^; 621.4412\[M − (Glc/Glc) \]^−^                                                                                                                                          Gypenoside XVII                                      CG, MCG~12~, MCG~20~               s
  89    11.81        C~51~H~84~O~21~      1032.5504              1032.5505               −0.1               1031.5431\[M − H\]^−^; 987.5535\[M − CO~2~\]^−^; 621.4412\[M − (Glc/Glc(mal))\]^−^; 179.0546\[Glc − H\]^−^                                                                                                                                     Isomer of malonylginsenoside Rd                      CG, MCG~12~, MCG~20~               \[[@B49-molecules-24-00033]\]
  90    11.88        C~48~H~82~O~18~      946.5476               946.55021               −2.6               969.5368\[M + Na\]^+^; 605.4394\[M − Glc/Glc\]^+^; 587.4312\[M − Glc/Glc − OH\]^+^; 425.3744\[M − Glc/Glc − Glc\]^+^; 407.3661\[M − Glc/Glc − OH − Glc\]^+^                                                                                    Chikusetsusaponin FK~1~                              CG, MCG~12~, MCG~20~               \[[@B40-molecules-24-00033]\]
  91    12.18        C~47~H~80~O~17~      916.5398               916.5396                0.2                961.5380\[M + HCOO\]^−^; 783.4870\[M − Xyl\]^−^; 621.4388\[M − (Xyl/glc)\]^−^                                                                                                                                                                  Notoginsenoside Fe                                   CG, MCG~12~, MCG~20~               s
  92    12.39        C~50~H~84~O~19~      988.5565               988.5607                −4.1               1011.5458\[M + Na\]^+^; 831.4819\[M − Glc\]^+^; 425.3763\[M − Glc/Glc(ace) − Glc\]^+^                                                                                                                                                          Quinquenoside III                                    CG, MCG~12~, MCG~20~               \[[@B51-molecules-24-00033]\]
  93    12.45        C~47~H~80~O~17~      916.5376               916.5396                −2.1               939.5268\[M + Na\]^+^; 789.4754\[M − 2 × OH − CH~6~O~3~\]^+^                                                                                                                                                                                   Vinaginsenoside R~16~                                CG, MCG~12~, MCG~20~               \[[@B40-molecules-24-00033]\]
  94    12.59        C~47~H~80~O~17~      916.5361               916.5396                −3.7               939.5253\[M + Na\]^+^; 407.3672\[M − Glc − (Glc/Xyl) − OH\]^+^                                                                                                                                                                                 Gypenoside IX                                        CG, MCG~12~, MCG~20~               \[[@B52-molecules-24-00033]\]
  95    12.91        C~50~H~84~O~19~      988.5569               988.5607                −3.8               1011.5461\[M + Na\]^+^; 789.4784\[M − Glc − 2 × OH\]^+^                                                                                                                                                                                        Quinquenoside III isomer                             CG, MCG~12~, MCG~20~               \[[@B51-molecules-24-00033]\]
  96    13.29        C~52~H~86~O~19~      1014.5753              1014.5763               −1.0               1037.5645\[M + Na\]^+^; 857.5032\[M − C~4~H~8~O~4~ − 2 × OH\]^+^; 393.1376\[Glc/Glc(ace) − OH\]^+^                                                                                                                                             Quinquenoside I                                      CG, MCG~12~, MCG~20~               \[[@B53-molecules-24-00033]\]
  97    13.34        C~42~H~72~O~13~      784.4984               784.4973                1.4                829.4966\[M + HCOO\]^−^; 621.4373\[M − Glc\]^−^; 161.0437\[Glc − H − H~2~O\]^−^                                                                                                                                                                Ginsenoside F~2~                                     CG, MCG~12~, MCG~20~               s
  98    13.55        C~42~H~72~O~13~      784.4977               784.4973                0.5                807.4869\[M + Na\]^+^; 605.4402\[M − Glc\]^+^; 587.4286\[M − Glc − OH\]^+^; 425.3765\[M − Glc/Glc − OH\]^+^; 407.3659\[M − Glc/Glc − 2 × OH\]^+^                                                                                               20(*R*)-Ginsenoside Rg~3~                            CG, MCG~12~, MCG~20~               s
  99    13.57        C~17~H~24~O~2~       260.1774               260.1776                −0.8               261.1847\[M + H\]^+^                                                                                                                                                                                                                           Panaxydol                                            ^∆∆,\#\#^ CG, MCG~12~, MCG~20~     \[[@B54-molecules-24-00033]\]
  100   13.77        C~42~H~66~O~14~      794.4464               794.4453                1.4                793.4391\[M − H\]^−^; 731.4375\[M − CO~2~ − OH\]^−^; 613.3746\[M − Glc\]^−^                                                                                                                                                                    Chikusetsusaponin Iva                                CG, MCG~12~, MCG~20~               \[[@B51-molecules-24-00033]\]
  101   14.02        C~52~H~86~O~19~      1014.5750              1014.5763               −1.3               1037.5642\[M + Na\]^+^; 789.4732\[M − Glc − C~2~H~4~O~2~\]^+^                                                                                                                                                                                  Isomer of Quinquenoside I                            CG, MCG~12~, MCG~20~               \[[@B51-molecules-24-00033]\]
  102   14.38        C~17~H~26~O~3~       278.1879               278.1882                −1.1               279.1952\[M + H\]^+^                                                                                                                                                                                                                           Panaxtriol                                           CG, MCG~12~, MCG~20~               \[[@B55-molecules-24-00033]\]
  103   14.46        C~42~H~72~O~13~      784.4970               784.4973                −0.3               829.4966\[M + HCOO\]^−^; 621.4373\[M − Glc\]^−^; 407.3672\[M − Glc/Glc − 2 × OH\]^+^                                                                                                                                                           20(*S*)-Ginsenoside Rg~3~                            CG, MCG~12~, MCG~20~               s
  104   15.05        C~18~H~34~O~4~       314.2444               314.2457                −3.8               337.2336\[M + Na\]^+^                                                                                                                                                                                                                          Dibutyl sebacate                                     CG, MCG~12~, MCG~20~               a
  105   17.90        C~16~H~22~O~4~       278.1516               278.1518                −0.7               301.1408\[M + Na\]^+^; 149.0230\[M − C~4~H~9~ − C~4~H~9~O\]^+^                                                                                                                                                                                 *n*-Butyl isobutyl phthalate                         CG, MCG~12~, MCG~20~               a
  106   17.93        C~30~H~52~O~4~       476.3856               476.3866                −2.2               499.3747\[M + Na\]^+^; 441.3728\[M − 2 × OH\]^+^; 423.3590\[M − 3 × OH\]^+^; 317.2049\[M − 2 × CH~3~ − C~8~H~15~O\]^+^                                                                                                                         20(*R*)-Protopanaxatriol                             CG, MCG~12~, MCG~20~               \[[@B56-molecules-24-00033]\]
  107   17.95        C~16~H~30~O~2~       254.2246               254.2268                8.2                277.2161\[M + Na\]^+^                                                                                                                                                                                                                          Palmitoleic acid                                     CG, ^∆,^\*\* MCG~12~, MCG~20~      s
  108   18.07        C~19~H~18~O~3~       294.1258               294.1256                0.5                317.1150\[M + Na\]^+^                                                                                                                                                                                                                          Tashinone IIA                                        CG, MCG~12~, MCG~20~               \[[@B57-molecules-24-00033]\]
  109   18.08        C~30~H~48~O~4~       472.3546               472.3553                −1.4               495.3438\[M + Na\]^+^                                                                                                                                                                                                                          β-Amyrone                                            CG, MCG~12~, MCG~20~               \[[@B58-molecules-24-00033]\]
  110   18.08        C~6~H~6~O~3~         126.0331               126.0317                9.4                149.0223\[M + Na\]^+^                                                                                                                                                                                                                          Pyrogallol                                           CG, MCG~12~, MCG~20~               a
  111   18.09        C~30~H~48~O~4~       472.3546               472.3553                −1.8               495.3438\[M + Na\]^+^                                                                                                                                                                                                                          24-Hydroxyoleanolic acid                             CG, ^∆∆,^\*\* MCG~12~, MCG~20~     \[[@B59-molecules-24-00033]\]
  112   18.09        C~24~H~38~O~5~       406.2720               406.2719                0.3                429.2613\[M + Na\]^+^; 319.1950\[M − CH~3~ − C~4~H~7~O\]^+^; 261.2213\[M − 2 × C~2~H~4~O~2~ − C~2~H~3~\]^+^;                                                                                                                                   Vitetrifolin                                         CG, MCG~12~, MCG~20~               a
  113   20.14        C~31~H~46~O~2~       450.3535               450.3498                8.0                473.3428\[M + Na\]^+^; 430.2889\[M − C~3~H~7~\]^+^                                                                                                                                                                                             Vitamin K~1~                                         CG, MCG~12~, MCG~20~               \[[@B60-molecules-24-00033]\]
  114   20.97        C~18~H~30~O~2~       278.2224               278.2252                −7.9               277.2151\[M − H\]^−^; 232.2172\[M − COOH\]^−^                                                                                                                                                                                                  α-Linolenic acid                                     ^∆∆,\#\#^ CG, MCG~12~, MCG~20~     \[[@B61-molecules-24-00033]\]
  115   21.18        C~21~H~38~O~4~       354.2758               354.2770                −3.1               377.2650\[M + Na\]^+^                                                                                                                                                                                                                          β-Monolinolein                                       CG, MCG~12~, MCG~20~               \[[@B62-molecules-24-00033]\]
  116   22.11        C~18~H~32~O          264.2452               264.2453                −0.5               265.2525\[M + H\]^+^; 149.1320\[M − CH~2~ − C~6~H~12~O\]^+^; 135.1166\[M − CH~2~ − C~7~H~13~O\]^+^; 121.1008\[M − CH~2~ − C~8~H~15~O\]^+^; 109.1010\[M − C~8~H~15~O − C~2~H~3~\]^+^                                                            (Z)-9,17-Octadecadienal                              CG, MCG~12~, MCG~20~               \[[@B63-molecules-24-00033]\]
  117   22.49        C~18~H~32~O~2~       280.2386               280.2402                −5.9               279.2313\[M − H\]^−^; 234.2325\[M − COOH\]^−^                                                                                                                                                                                                  Linoleic acid                                        ^∆∆,\#\#^ CG, MCG~12~, MCG~20~     s
  118   23.85        C~14~H~20~O~2~       220.1478               220.1463                5.6                265.1460\[M + HCOO\]^−^                                                                                                                                                                                                                        Thymyl isobutyrate                                   CG, MCG~12~, MCG~20~               \[[@B64-molecules-24-00033]\]
  119   24.25        C~18~H~34~O~2~       282.2541               282.2559                −6.3               281.2468\[M − H\]^−^; 236.2481\[M − COOH\]^−^                                                                                                                                                                                                  9-Octadecenoic acid                                  ^∆∆,\#\#^ CG, MCG~12~, MCG~20~     a
  120   24.40        C~36~H~62~O~8~       622.4454               622.4445                1.6                623.4527\[M + H\]^+^; 316.2842\[M − OH − Glc − C~8~H~14~\]^+^;                                                                                                                                                                                 Compound K                                           CG, MCG~12~, MCG~20~               \[[@B40-molecules-24-00033]\]
  121   24.89        C~40~H~56~O~4~       600.4219               600.4179                6.7                601.4292\[M + H\]^+^; 557.4021\[M − C~2~H~4~\]^+^                                                                                                                                                                                              Violaxanthin                                         CG, MCG~12~, MCG~20~               \[[@B65-molecules-24-00033]\]
  122   25.31        C~20~H~38~O~2~       310.2862               310.2872                −3.2               311.2935\[M + H\]^+^; 277.1995\[M − C~6~H~13~\]^+^                                                                                                                                                                                             Ethyloleate                                          CG, MCG~12~, MCG~20~               a
  123   25.35        C~40~H~56~O~4~       600.4212               600.4179                5.6                601.4285\[M + H\]^+^; 497.3800\[M − OH − C~4~H~8~O~2~\]^+^                                                                                                                                                                                     Neoxanthine                                          CG, MCG~12~, MCG~20~               \[[@B65-molecules-24-00033]\]
  124   26.38        C~24~H~38~O~4~       390.2758               390.2770                −2.8               413.2653\[M + Na\]^+^; 301.1406\[M − 3 × C~2~H~5~\]^+^; 189.0153\[M − C~2~H~5~ − C~4~H~9~ − C~8~H~17~\]^+^; 167.0327\[M − 2 × C~2~H~17~\]^+^                                                                                                   Bis(2-ethylhexyl) phthalate                          CG, MCG~12~, MCG~20~               a
  125   28.01        C~30~H~46~O~5~       486.3334               486.3345                −2.2               509.3226\[M + Na\]^+^                                                                                                                                                                                                                          Quillaic acid                                        CG, MCG~12~, MCG~20~               s
  126   29.04        C~5~H~8~O~2~         100.0512               100.0524                −10.0              123.0404\[M + Na\]^+^                                                                                                                                                                                                                          Pentanedial                                          CG, MCG~12~, MCG~20~               \[[@B66-molecules-24-00033]\]

^s^ Identified with standard. ^a^ Compared with spectral data obtained from Wiley Subscription Services, Inc. (USA). ^∆^, ^∆∆^: Represented the content either in CG~4--6\ years~ group or in MCG~12\ years~ group was significantly higher than the other one (^∆^ *p* \< 0.05, ^∆∆^ *p* \< 0.001) ^\#^,^\#\#^: Represented the content either in CG~4--6\ years~ group or in MCG~20\ years~ group was significantly higher than the other one (^\#^ *p* \< 0.05, ^\#\#^ *p* \< 0.001) \*, \*\*: Represented the content either in MCG~12\ years~ group or in MCG~20\ years~ group was significantly higher than the other one (\* *p* \< 0.05, \*\* *p* \< 0).

molecules-24-00033-t003_Table 3

###### 

The summary table with variable identity, VIP and p value.

  Groups for Comparison                     Marker' Name               VIP Value          *p* Value   
  ----------------------------------------- -------------------------- ------------------ ----------- ---------
  CG~4--6\ years~ vs. MCG~12\ years~        CG~4--6\ years~            α-linolenic acid   1.23        \<0.001
  9-octadecenoic acid                       2.17                       \<0.001                        
  linoleic acid                             2.57                       \<0.001                        
  panaxydol                                 1.49                       \<0.001                        
  MCG~12\ years~                            24-hydroxyoleanolic acid   4.13               \<0.001     
  ginsenoside F3                            2.15                       \<0.001                        
  palmitoleic acid                          1.54                       0.037                          
  CG~4--6\ years~ vs. MCG~20\ years~        MCG~20\ years~             ginsenoside Re1    1.60        \<0.001
  ginsenoside Re2                           1.75                       \<0.001                        
  ginsenoside Rs1                           1.59                       \<0.001                        
  malonylginsenoside Rb2                    4.10                       \<0.001                        
  ginsenoside Rf                            1.83                       \<0.001                        
  isomer of malonylginsenoside Rb1          2.30                       \<0.001                        
  quinquenoside R1                          1.21                       \<0.001                        
  CG~4-6\ years~                            ginsenoside Ro             1.39               0.017       
  isomer of ginsenoside Ro                  2.31                       0.022                          
  12,13,15-trihydroxy-9-octadecenoic acid   1.25                       0.003                          
  linoleic acid                             7.08                       \<0.001                        
  9-octadecenoic acid                       3.45                       \<0.001                        
  α-linolenic acid                          1.86                       \<0.001                        
  panaxydol                                 1.12                       \<0.001                        
  MCG~12\ years~ vs. MCG~20\ years~         MCG~12\ years~             palmitoleic acid   2.07        \<0.001
  24-hydroxyoleanolic acid                  3.26                       \<0.001                        
  MCG~20\ years~                            ginsenoside Re1            1.16               0.002       
  ginsenoside Rs1                           1.89                       0.024                          
  malonylginsenoside Rb2                    2.76                       0.026                          
  ginsenoside Re2                           1.60                       \<0.001                        
  isomer of malonylginsenoside-Rb1          3.87                       \<0.001                        
